Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis

Jaeil Shin, Se Jin Park, Ji Hong Kim

Research output: Contribution to journalLetter

Original languageEnglish
Number of pages1
JournalKidney International
Volume79
Issue number8
DOIs
Publication statusPublished - 2011 Apr 1

Fingerprint

Schoenlein-Henoch Purpura
Fibrinolytic Agents
Nephritis
Urokinase-Type Plasminogen Activator
Fibrinolysis
Combination Drug Therapy
Cyclophosphamide
Steroids

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

@article{5fb46c237b2546d59e5ad012b40e004c,
title = "Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Sch{\"o}nlein nephritis",
author = "Jaeil Shin and Park, {Se Jin} and Kim, {Ji Hong}",
year = "2011",
month = "4",
day = "1",
doi = "10.1038/ki.2011.5",
language = "English",
volume = "79",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "8",

}

Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis. / Shin, Jaeil; Park, Se Jin; Kim, Ji Hong.

In: Kidney International, Vol. 79, No. 8, 01.04.2011.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis

AU - Shin, Jaeil

AU - Park, Se Jin

AU - Kim, Ji Hong

PY - 2011/4/1

Y1 - 2011/4/1

UR - http://www.scopus.com/inward/record.url?scp=79953233358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953233358&partnerID=8YFLogxK

U2 - 10.1038/ki.2011.5

DO - 10.1038/ki.2011.5

M3 - Letter

VL - 79

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 8

ER -